We are live on ! Find out more
CODX icon

Co-Diagnostics
CODX

5 hedge funds and large institutions have $625K invested in Co-Diagnostics in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,143% more capital inflows, than outflows

Capital inflows: $97.3K | Capital outflows: $3K

0.23% more ownership

Funds ownership: 1.7% → 1.93% (+0.23%)

29% less funds holding

Funds holding: 7 → 5 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$49.5K
2
Citadel Advisors
Citadel Advisors
Florida
+$45.2K
3
UBS Group
UBS Group
Switzerland
+$2.57K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$1K
2
Ladenburg Thalmann Financial Services
Ladenburg Thalmann Financial Services
Florida
-$1K
3
Morgan Stanley
Morgan Stanley
New York
-$1K

CODX Hedge Fund Activity: Q3 2018 in Review

5 of the 4,392 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q3 2018, worth a combined $625K — down 23% from $812K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CODX and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Vanguard Group, adding an estimated $49.5K. The largest seller was Deutsche Bank, exiting entirely with an estimated $1K sold.

  • 5 institutional investors held Co-Diagnostics (CODX) as of Q3 2018, down from 7 in Q2 2018.
  • Funds reported $625K of Co-Diagnostics stock for Q3 2018, down 23% quarter-over-quarter.
  • 1 fund opened new Co-Diagnostics positions in Q3 2018 and 3 closed out, a net change of -2 holders.
  • The largest Co-Diagnostics buyer in Q3 2018 was Vanguard Group, an estimated $49.5K added.
  • The largest Co-Diagnostics seller in Q3 2018 was Deutsche Bank, an estimated $1K sold.

Based on aggregated 13F filings for Q3 2018.